Clinical Trials Browser

Interleukin-12 × Tumor-Agnostic × Clear all

NCT03030378 2026-04-13

Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors

Phase 1 Active not recruiting

Neoplasm Metastasis